Nose-to-Brain delivery of insulin for Alzheimer’s disease
Martina Stützle(University of Applied Sciences Biberach), Katharina Schindowski(University of Applied Sciences Biberach), Stefan Carle(Boehringer Ingelheim (Germany)), J Flamm(University of Applied Sciences Biberach)
Cited by 35
Related Papers
Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa
|Pharmaceutics|2018|415
Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits
|American Journal Of Pathology|2006|383
Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates
|Pharmaceutics|2022|93
A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery
|International Journal of Pharmaceutics|2017|55
An in-depth examination of fatty acid solubility limits in biotherapeutic protein formulations containing polysorbate 20 and polysorbate 80
|International Journal of Pharmaceutics|2020|47